Novel CHK1 Inhibitor MU380 Exhibits Significant Single-Agent Activity in TP53-mutated Chronic Lymphocytic Leukemia Cells

Haematologica - Italy
doi 10.3324/haematol.2018.203430
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Therapeutic Inhibition of USP7-PTEN Network in Chronic Lymphocytic Leukemia: A Strategy to Overcome TP53 Mutated/Deleted Clones

Oncotarget
Oncology
2017English

Unravelling the Suboptimal Response of TP53 -Mutated Chronic Lymphocytic Leukaemia to Ibrutinib

British Journal of Haematology
Hematology
2018English

Genetic Characterization of SF3B1 Mutations in Single Chronic Lymphocytic Leukemia Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

Novel Agents for Chronic Lymphocytic Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

TP53 Gene Mutation Analysis in Chronic Lymphocytic Leukemia by Nanopore MinION Sequencing

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2016English

Regulatory T-Cells in Chronic Lymphocytic Leukemia

Mediterranean Journal of Hematology and Infectious Diseases
Infectious DiseasesHematology
2012English

Chronic Lymphocytic Leukemia

Current Opinion in Hematology
Hematology
1998English

Chronic Lymphocytic Leukemia

Orvosi Hetilap
Medicine
2008English

Chronic Lymphocytic Leukemia

ASH Image Bank
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy